At 114 times sales, Palantir's stock is mind-bogglingly expensive. Most software companies trade in the range of 10 to 20 ...

Iovance Biotherapeutics has proven to be an innovative biotech. Over the past two years, Iovance Biotherapeutics (NASDAQ: ...